Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Interferon-Alpha and Sphingosine 1-Phosphate

Research Papers that Mention the Interaction

A combination of tumor necrosis factor alpha (TNF‐α), lipopolysaccharide (LPS), and interferon gamma IFN‐γ ) strongly decreased S1P production that resulted in abnormal lysosome enlargement and cell death associated with mitochondrial dysfunction of glioma cells only.
Glia  •  2010  |  View Paper
S1P decreased CD4 T cell generation of IFN-γ and IL-4, without affecting IL-2.
S1P then evoked chemotaxis, inhibited chemotaxis to CCL-5 and CCL-21, and suppressed Ag-stimulated proliferation and IFN-γ production.
The Journal of Immunology  •  2003  |  View Paper
S1P significantly reduced the release of IL-17A and IFN-γ from NK cells, but this inhibition was S1P1-independent.
Cancer Immunology, Immunotherapy  •  2009  |  View Paper
S1P enhanced proliferation and IFN-γ production by CD4+ T cells.
The enhancing effect of S1P on IFN-γ production by CD4+ T cells was stronger in patients with primary SS than in healthy controls.
The Journal of Immunology  •  2008  |  View Paper
Here, we report that sphingosine 1-phosphate (S1P)-S1PR1 signaling in plasmacytoid dendritic cells (pDCs) directly inhibits IFN-α autoamplification by induced degradation of the interferon alpha receptor 1 (IFNAR1) receptor and suppression of signal transducer and activator of transcription 1 (STAT1) signaling.
Proceedings of the National Academy of Sciences  •  2016  |  View Paper
IFN-α , generated by plasmacytoid dendritic cells, induced the expression of CD69 and suppressed the sphingosine-1-phosphate-induced chemotactic response, promoting FO-oriented Ag transport by MZ-P B cells.
The Journal of Immunology  •  2009  |  View Paper
As for IL-23 enhancement of Th17 cell development, that by S1P was prevented by IL-4 plus IFN-γ and by IL-27.
The Journal of Immunology  •  2007  |  View Paper
Secretion of IL‐4 by S1P4‐D10G4.1 cells, IL‐2 by S1P4‐EL4.IL‐2, and IFN‐γ by FTY720‐treated CD4 T cells were significantly inhibited by S1P.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology  •  2005  |  View Paper